Psoriasis International Newsletter n°7
2009 March 06
In this number, several issues deserve your attention :
- a focus on Europso’s 2008 activities
- the 2nd World Psoriasis and Psoriatic Arthritis Conference, organised by IFPA in June 2009
- the withdrawal of Raptiva and the call upon an international discussion on the practical strategies being taken in light of this event
- the renewal of the French Psoriasis Group’s Scientific Board
- the development of our homepage highlighting the constitution of three Boards to further develop and liven up the network
You will also find here the latest psoriasis articles published in PubMed.
Recent publications on psoriasis
Follow this link to visit Pubmed’s page summarizing publications on Psoriasis in the last 30 days.
> Visit...Focus on...
EUROPSO’s 2008 activities
EUROPSO’s 2008 activities The executive board of Europso had meetings in 2008 Frankfurt and Paris. We made a new website: http://www.europso.eu/ EADV congress The Europso board was present in Paris at the EADV congress!!!! 17th EADV (...)
> Read more...News from the web office
Development of Psoriasis International Homepage
In February, the homepage of Psoriasis-international.org has been developed to include a direct link highlighting the three boards of the network, which are currently under formation. A Scientific Board, an Advisory Board and a Pharmaceutical (...)
> Read more...Events
2nd World Psoriasis and Psoriatic Arthritis Conference
Fast facts 2nd World Psoriasis and Psoriatic Arthritis Conference Theme: Skin and beyond Dates: June 24 – June 28, 2009 Venue: Stockholm City Centre, Sweden Target group: Dermatologists, Rheumatologists and Allied Health Professionals (...)
> Read more...News from medical groups
Suspension of Market Authorisation of Raptiva
Following the decision of EMEA and FDA, Raptiva will be withdrawn in the next weeks due to the risk of LEMP. We are now discussing, within the French Psoriasis Group, on the best strategy to shift to another treatment. It would be quite (...)
> Read more...French Psoriasis Group renews its Scientific Board
The French Psoriasis Group has just proceeded to the partial renewal of its Scientific Board. In accordance with its statutes, the renewal was made by the anonymous vote of the Group’s members. The new Scientific Board, elected for 2 years, is (...)
> Read more...